Strategic Partnerships Admera Health actively pursues collaborations with leading genomics and biotech players (including 10x Genomics and Complete Genomics) and academic institutions (ODU), presenting clear avenues for co-promotional services, joint grant opportunities, and bundled sequencing offerings to expand market reach.

Service Expansion Recent launches such as whole-genome sequencing on the Illumina NovaSeq X Plus and spatial transcriptomics grants position Admera Health to upsell advanced sequencing and analytical services to existing biopharma and research clients seeking comprehensive genomic solutions.

Genomics AI Investments in generative AI platforms for Alzheimer's research and ongoing bioinformatics capabilities create a sales opening to offer AI-assisted analysis, data interpretation, and customized report generation for academic and industry customers exploring AI-enabled genomic insights.

Certifications & Trust CLIA/CLEP-certified and CAP-accredited operations provide a strong credibility signal for regulated research and clinical projects, enabling targeted outreach to biopharma companies and contract research organizations prioritizing quality, traceability, and compliance.

Funding & Grants Active grant-backed collaborations and a grant program with industry partners create opportunities to structure funded projects, pilot studies, and sponsor-supported sequencing initiatives that reduce client risk and accelerate engagement timelines.